Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.03 | 20.40 |
| PEG Ratio (TTM) | 0.00 | 2.09 |
| P/S Ratio (TTM) | 0.05 | 1.42 |
| P/B Ratio (TTM) | 0.01 | 5.70 |
| P/FCF Ratio (TTM) | -0.25 | 13.94 |
| Price to 5YR AVG Earnings Ratio | -0.01 | 20.85 |
| Price to 5YR AVG FCF Ratio | -0.28 | 16.40 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -14.84% | 4.94% |
| ROE (TTM) | -35.79% | 32.02% |
| Net Profit Margin (TTM) | -28.81% | 4.76% |
| ROIC 5YR AVG | -49.23% | 14.55% |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 57.99% | 4.48% | -3.99% |
| Revenue | 22.08% | 29.48% | 52.65% |
| Net Income | 26.03% | -16.89% | -41.78% |
| Cash Flow | -6.98% | -368.12% | -224.65% |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.61 | 1.61 |
| Quick Ratio (TTM) | 0.35 | 0.89 |
| D/E Ratio (TTM) | 0.33 | 1.27 |
| Interest Coverage (TTM) | -11.89 | 18.73 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | N/A | 3.60 |
| LTL to 5YR AVG FCF | -1.14 | 7.23 |
| Shares Outstanding Growth 5YR AVG | 74.84% | -2.31% |